Why the study?
Is robotic beating heart totally endoscopic coronary artery bypass (BH-TECAB) safe and feasible in morbidly obese patients compared to non-morbidly obese patients?
Is robotic beating heart totally endoscopic coronary artery bypass (BH-TECAB) safe and feasible in morbidly obese patients compared to non-morbidly obese patients?
Answers are grounded in this paper and cite their sources.
Robotic beating heart totally endoscopic coronary artery bypass is feasible in morbidly obese patients, yielding similar mortality and morbidity to non-obese patients despite a higher risk of prolonged ventilation.
BACKGROUND: We investigated the outcomes of morbidly obese patients after robotic beating heart totally endoscopic coronary artery bypass (BH-TECAB). METHODS: This is a retrospective single center study. From July 2013 to December 2016, the outcomes of patients undergoing BH-TECAB were reviewed. RESULTS: A total of 234 patients underwent BH-TECAB (172 male, mean age 65.2 years). There were 43 morbidly obese patients defined as body mass index (BMI) greater than 35, and 191 non-morbidly obese patients. Postoperative complications, or mortality in morbidly obese and other patients were similar except for prolonged ventilation >24 h (11.6% vs 2.1%, P = 0.008). CONCLUSIONS: Morbidly obese patients had an increased incidence of prolonged ventilation after BH-TECAB, but an otherwise reasonably low morbidity and mortality similar to patients with a lower BMI. We believe that adoption of robotics technology allows for BH-TECAB and can lead to improved outcomes in this high-risk population.
No takes yet. Share an insight, caveat, or question.
Kitahara et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: